Voyageur Pharmaceuticals Ltd. reported earnings results for the full year ended November 30, 2023. For the full year, the company reported net loss was CAD 1.4 million compared to CAD 1.75 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -16.67% | -28.57% | -33.33% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 6.14M | |
+57.48% | 823B | |
-7.18% | 353B | |
+15.37% | 320B | |
+7.45% | 295B | |
+13.62% | 239B | |
+14.55% | 220B | |
-0.33% | 219B | |
+8.14% | 167B | |
-2.99% | 159B |
- Stock Market
- Equities
- VM Stock
- News Voyageur Pharmaceuticals Ltd.
- Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023